Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Impact of the Overexpression of the Tyrosine Kinase Receptor RET in the Hematopoietic Potential of Induced Pluripotent Stem Cells (iPSCs)

Version 1 : Received: 16 May 2023 / Approved: 17 May 2023 / Online: 17 May 2023 (13:49:58 CEST)

A peer-reviewed article of this Preprint also exists.

Marcoux, P.; Imeri, J.; Desterke, C.; Latsis, T.; Chaker, D.; Hugues, P.; Griscelli, A.B.; Turhan, A.G. Impact of the Overexpression of the Tyrosine Kinase Receptor (RET) in the Hematopoietic Potential of Induced Pluripotent Stem Cells (IPSCs). Cytotherapy 2023, doi:10.1016/j.jcyt.2023.10.003. Marcoux, P.; Imeri, J.; Desterke, C.; Latsis, T.; Chaker, D.; Hugues, P.; Griscelli, A.B.; Turhan, A.G. Impact of the Overexpression of the Tyrosine Kinase Receptor (RET) in the Hematopoietic Potential of Induced Pluripotent Stem Cells (IPSCs). Cytotherapy 2023, doi:10.1016/j.jcyt.2023.10.003.

Abstract

Introduction: Previous studies have suggested that the tyrosine kinase receptor RET plays a sig-nificant role in the hematopoietic potential in mice and could also be used to expand cord-blood derived hematopoietic stem cells (HSCs). The role of RET in the human iPSC-derived hematopoi-esis has not been tested so far. Methods: To test the implication of RET on the hematopoietic potential of iPSCs, we activated its pathway with the lentiviral overexpression of RETWT or RETC634Y mutation in normal iPSCs. An iPSC derived from a patient harboring the RETC634Y mutation (iRETC634Y) and its CRISPR-corrected isogenic control iPSC (iRETCTRL) were also used. Hematopoietic potential was tested using 2D cul-tures and evaluated regarding the phenotype and the clonogenic potential of generated cells. Results: Hematopoietic differentiation from iPSCs with RET overexpression (WT or C634Y) led to a significant reduction in the number and in the clonogenic potential of HSCs (CD34+/CD38-/CD49f+) as compared to control iPSCs. Similarly, the hematopoietic potential of iRETC634Y was reduced as compared to iRETCTRL. Transcriptomic analyses revealed a specific ac-tivated expression profile for iRETC634Y compared to its control with evidence of overexpression of genes which are part of the MAPK network with negative hematopoietic regulator activities. Conclusion: RET activation in iPSCs is associated with an inhibitory activity in iPSC-derived hematopoiesis, potentially related with MAPK activation.

Keywords

iPSCs; HSCs; RET; Hematopoietic differentiation; CD34

Subject

Biology and Life Sciences, Cell and Developmental Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.